SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-313011"
 

Search: id:"swepub:oai:DiVA.org:uu-313011" > Lymphovascular and ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Lymphovascular and perineural invasion in stage II rectal cancer : a report from the Swedish colorectal cancer registry

Nikberg, Maziar (author)
Uppsala universitet,Centrum för klinisk forskning, Västerås
Chabok, Abbas (author)
Uppsala universitet,Centrum för klinisk forskning, Västerås
Letocha, Henry (author)
Uppsala universitet,Centrum för klinisk forskning, Västerås
show more...
Kindler, Csaba (author)
Uppsala universitet,Centrum för klinisk forskning, Västerås
Glimelius, Bengt (author)
Uppsala universitet,Experimentell och klinisk onkologi
Smedh, Kennet (author)
Uppsala universitet,Centrum för klinisk forskning, Västerås
show less...
 (creator_code:org_t)
2016
2016
English.
In: Acta Oncologica. - 0284-186X .- 1651-226X. ; 55:12, s. 1418-1424
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Adjuvant chemotherapy for stage II and III rectal cancer patients is a matter of discussion. The aim of the present study was to evaluate the prognostic value of lymphovascular (LVI) and perineural (PNI) invasion in stage II rectal cancer on a national level. Materials and methods: Clinico-pathological factors associated with disease-free survival (DFS) and time to recurrence in stage II rectal cancer patients were analyzed from patient data registered in the Swedish Colorectal Cancer Registry between 2006 and 2012. Results: Of 2649 patients with TNM stage II disease, 1395 (53%) received preoperative radiotherapy and 456 (17%) preoperative chemoradiotherapy. LVI and PNI were detected in 387 (15%) and 269 (10%) patients, respectively. Adjuvant chemotherapy was planned in 14%, but more often if LVI or PNI was detected (25% and 31%, respectively, p < .001 for both). The three-year DFS and time to recurrence were 78% and 17%, respectively. Both LVI and PNI indicated worse outcome. In patients not receiving postoperative chemotherapy, the risks of recurrence after three years were 20% if LVI was seen and 22% if PNI was detected (p < .001 for both). In the absence of LVI and PNI, it was 13% and 12%, respectively. In a multivariate Cox regression analysis, patients with LVI (hazard ratio 1.44, 95% CI 1.09-1.90; p = .011) and PNI (hazard ratio 1.80, 95% CI 1.34-2.43, p < .001) had significantly increased risks of recurrence. Conclusions: Stage II rectal cancer patients with LVI and PNI have an increased risk of recurrence which emphasizes the need to properly evaluate the role of adjuvant chemotherapy particularly in these subgroups.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Nikberg, Maziar
Chabok, Abbas
Letocha, Henry
Kindler, Csaba
Glimelius, Bengt
Smedh, Kennet
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Cancer and Oncol ...
Articles in the publication
Acta Oncologica
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view